-transparent.png){kind=logo}
It has been proposed that loss of genes at specific chromosomal loci leads to tumorigenesis in some human tumors. This type of oncogenesis was first demonstrated in retinoblastoma and Wilms' tumor. Recently, it has been reported that acoustic neuroma, ductal breast tumor, and renal cell carcinoma may be caused by the same mechanism. Cytogenetic studies demonstrated that some meningiomas have monosomy of chromosome 22. In addition, human meningiomas are often associated with bilateral acoustic neuroma in which specific loss of alleles on chromosome 22 has been demonstrated. Then, we compared constitutional and tumor genotypes from 14 cases of sporadic human meningiomas, using four polymorphic DNA probes on chromosome 22 (SIS, D22S1, D22S9, IGLC). Loss of constitutional heterozygosity was found in three of 11 informative cases. Two of the three meningiomas maintained constitutional heterozygosity at the IGLC locus and another one showed no loss of heterozygosity at IGLC or D22S9. These results suggest that loss of genes on chromosome 22 caused by either a partial deletion or a mitotic recombination at a locus distal to D22S9 plays an important role in tumorigenesis of the human meningioma.
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
January 1995,
International journal of cancer,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
November 1992,
Genes, chromosomes & cancer,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
August 2002,
World journal of gastroenterology,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
November 1988,
Journal of medical genetics,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
January 1986,
Nature,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
January 2000,
Anticancer research,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
January 1989,
Genomics,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
August 1987,
Proceedings of the National Academy of Sciences of the United States of America,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
December 1987,
Japanese journal of cancer research : Gann,
M Okazaki, and
I Nishisho, and
H Tateishi, and
K Motomura, and
M Yamamoto, and
T Miki, and
T Hayakawa, and
S Takai, and
T Honjo, and
T Mori
February 1992,
International journal of cancer,
